These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 31952845)

  • 1. Three-Variate Longitudinal Patterns of Metabolic Control, Body Mass Index, and Insulin Dose during Puberty in a Type 1 Diabetes Cohort: A Group-Based Multitrajectory Analysis.
    Schwandt A; Kuss O; Dunstheimer D; Karges B; Kapellen T; Meissner T; Witsch M; Flury M; Straubinger S; Holl RW;
    J Pediatr; 2020 Mar; 218():64-71.e3. PubMed ID: 31952845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-variate trajectories of metabolic control, body mass index, and insulin dose: Heterogeneous response to initiation of pump therapy in youth with type 1 diabetes.
    Tauschmann M; Schwandt A; Prinz N; Becker M; Biester T; Hess M; Holder M; Karges B; Näke A; Kuss O; von Sengbusch S; Holl RW;
    Pediatr Diabetes; 2022 May; 23(3):330-340. PubMed ID: 35084795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proportion of Basal to Total Insulin Dose Is Associated with Metabolic Control, Body Mass Index, and Treatment Modality in Children with Type 1 Diabetes-A Cross-Sectional Study with Data from the International SWEET Registry.
    Rasmussen VF; Vestergaard ET; Schwandt A; Beltrand J; Rami-Merhar B; O'Riordan SMP; Jarosz-Chobot P; Castro-Correia C; Gevers EF; Birkebæk NH
    J Pediatr; 2019 Dec; 215():216-222.e1. PubMed ID: 31345576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trajectories of Body Mass Index from Childhood to Young Adulthood among Patients with Type 1 Diabetes-A Longitudinal Group-Based Modeling Approach Based on the DPV Registry.
    Prinz N; Schwandt A; Becker M; Denzer C; Flury M; Fritsch M; Galler A; Lemmer A; Papsch M; Reinehr T; Rosenbauer J; Holl RW
    J Pediatr; 2018 Oct; 201():78-85.e4. PubMed ID: 29937081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal Trajectories of Metabolic Control From Childhood to Young Adulthood in Type 1 Diabetes From a Large German/Austrian Registry: A Group-Based Modeling Approach.
    Schwandt A; Hermann JM; Rosenbauer J; Boettcher C; Dunstheimer D; Grulich-Henn J; Kuss O; Rami-Merhar B; Vogel C; Holl RW;
    Diabetes Care; 2017 Mar; 40(3):309-316. PubMed ID: 28007778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five heterogeneous HbA1c trajectories from childhood to adulthood in youth with type 1 diabetes from three different continents: A group-based modeling approach.
    Clements MA; Schwandt A; Donaghue KC; Miller K; Lück U; Couper JJ; Foster N; Schröder C; Phelan H; Maahs D; Prinz N; Craig ME;
    Pediatr Diabetes; 2019 Nov; 20(7):920-931. PubMed ID: 31418521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choice of basal insulin therapy is associated with weight and height development in type 1 diabetes: A multicenter analysis from the German/Austrian DPV registry in 10 338 children and adolescents.
    Vollbach H; Auzanneau M; Reinehr T; Wiegand S; Schwab KO; Oeverink R; Froehlich-Reiterer E; Woelfle J; De Beaufort C; Kapellen T; Gohlke B; Holl RW
    J Diabetes; 2021 Nov; 13(11):930-939. PubMed ID: 34184423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct trajectories of HbA
    Rathmann W; Schwandt A; Hermann JM; Kuss O; Roden M; Laubner K; Best F; Ebner S; Plaumann M; Holl RW;
    Diabet Med; 2019 Nov; 36(11):1468-1477. PubMed ID: 31392761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin management and metabolic control of type 1 diabetes mellitus in childhood and adolescence in 18 countries. Hvidøre Study Group on Childhood Diabetes.
    Mortensen HB; Robertson KJ; Aanstoot HJ; Danne T; Holl RW; Hougaard P; Atchison JA; Chiarelli F; Daneman D; Dinesen B; Dorchy H; Garandeau P; Greene S; Hoey H; Kaprio EA; Kocova M; Martul P; Matsuura N; Schoenle EJ; Søvik O; Swift PG; Tsou RM; Vanelli M; Aman J
    Diabet Med; 1998 Sep; 15(9):752-9. PubMed ID: 9737804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemoglobin A1c (HbA1c) changes over time among adolescent and young adult participants in the T1D exchange clinic registry.
    Clements MA; Foster NC; Maahs DM; Schatz DA; Olson BA; Tsalikian E; Lee JM; Burt-Solorzano CM; Tamborlane WV; Chen V; Miller KM; Beck RW;
    Pediatr Diabetes; 2016 Aug; 17(5):327-36. PubMed ID: 26153338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Australasian Diabetes Data Network: first national audit of children and adolescents with type 1 diabetes.
    Phelan H; Clapin H; Bruns L; Cameron FJ; Cotterill AM; Couper JJ; Davis EA; Donaghue KC; Jefferies CA; King BR; Sinnott RO; Tham EB; Wales JK; Jones TW; Craig ME
    Med J Aust; 2017 Feb; 206(3):121-125. PubMed ID: 28208043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the use of diabetes technology with HbA1c and BMI-SDS in an international cohort of children and adolescents with type 1 diabetes: The SWEET project experience.
    Marigliano M; Eckert AJ; Guness PK; Herbst A; Smart CE; Witsch M; Maffeis C;
    Pediatr Diabetes; 2021 Dec; 22(8):1120-1128. PubMed ID: 34716736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term study of tubeless insulin pump therapy compared to multiple daily injections in youth with type 1 diabetes: Data from the German/Austrian DPV registry.
    Danne T; Schwandt A; Biester T; Heidtmann B; Rami-Merhar B; Haberland H; Müther S; Khodaverdi S; Haak T; Holl RW;
    Pediatr Diabetes; 2018 Aug; 19(5):979-984. PubMed ID: 29446511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term body weight trajectories and metabolic control in type 1 diabetes patients on insulin pump or multiple daily injections: A 10-year retrospective controlled study.
    Alderisio A; Bozzetto L; Franco L; Riccardi G; Rivellese AA; Annuzzi G
    Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1110-1117. PubMed ID: 31371264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of factors determining an HbA1c concentration ≤7.5% in patients with type 1 diabetes.
    Yamada E; Okada S; Nakajima Y; Bastie C; Tagaya Y; Osaki A; Shimoda Y; Shibusawa R; Saito T; Ozawa A; Yamada M
    J Diabetes; 2018 Feb; 10(2):140-147. PubMed ID: 28544548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Transatlantic HbA
    Hermann JM; Miller KM; Hofer SE; Clements MA; Karges W; Foster NC; Fröhlich-Reiterer E; Rickels MR; Rosenbauer J; DeSalvo DJ; Holl RW; Maahs DM;
    Diabet Med; 2020 May; 37(5):848-855. PubMed ID: 31557351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and long-term follow-up of patients diagnosed with type 1 diabetes mellitus before age 5.
    Ata A; Er E; Evin F; Işıklar H; Abdullayev N; Demir G; Özen S; Altınok YA; Darcan Ş; Gökşen D
    J Pediatr Endocrinol Metab; 2021 Feb; 34(2):201-207. PubMed ID: 33544547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual β-cell mass influences growth of prepubertal children with type 1 diabetes.
    Bizzarri C; Benevento D; Patera IP; Bongiovanni M; Boiani A; Fusco C; Cianfarani S; Cappa M
    Horm Res Paediatr; 2013; 80(4):287-92. PubMed ID: 24051686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 1 diabetes during adolescence: International comparison between Germany, Austria, and Sweden.
    Hanberger L; Samuelsson U; Holl RW; Fröhlich-Reiterer E; Åkesson K; Hofer S
    Pediatr Diabetes; 2018 May; 19(3):506-511. PubMed ID: 28940551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-year observation of the relationship between body mass index and glycated hemoglobin in children with Type 1 diabetes mellitus.
    Kadłubiska A; Małachowska B; Noiszewska K; Fendler W; Głowińska-Olszewska B; Bossowski A; Łuczyński W
    Scand J Clin Lab Invest; 2018 Sep; 78(5):398-406. PubMed ID: 29966439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.